Results of IFN-γ release assays from the 12 patients out of 17 with tests categorised as “failed”, in which the test failed as a result of a high nil control
Patient | Age(years) | Nil control(IU/ml IFN-γ) | ESAT-6(IU/ml IFN-γ) | ESAT-6 – Nil(IU/ml IFN-γ) | CFP-10(IU/ml IFN-γ) | CFP-10 – Nil(IU/ml IFN-γ) | Criteria 1* | Criteria 2* |
---|---|---|---|---|---|---|---|---|
*Criteria 1: Current guidelines at the time of our study (see text). Criteria 2: Modified guidelines from manufacturer US package insert and CDC2 which state that a test may be interpreted as positive when the background level of IFN-γ is above 0.7 IU/ml only if the response to the corrected ESAT-6 or CFP-10 result is at least 50% greater than the background level; otherwise the result is indeterminate. | ||||||||
†IFN-γ levels above 15 IU/ml cannot be measured accurately. | ||||||||
1 | 14 | 23.48† | 24.29† | 0.81 | 24.23† | 0.75 | Indeterminate | Indeterminate |
2 | 13 | 22.63† | 36.27† | 13.64 | 32.44† | 9.81 | Indeterminate | Indeterminate |
3 | 6 | 19.74† | 20.23† | 0.49 | 20.25† | 0.51 | Indeterminate | Indeterminate |
4 | 13 | 11.16 | 11 | −0.16 | 10.95 | −0.21 | Indeterminate | Indeterminate |
5 | 16 | 9.02 | 8.75 | −0.27 | 9.51 | 0.49 | Indeterminate | Indeterminate |
6 | 8 | 8.02 | 7.17 | −0.85 | 8.17 | 0.15 | Indeterminate | Indeterminate |
7 | 8 | 2.51 | 2.64 | 0.13 | 1.82 | −0.69 | Indeterminate | Indeterminate |
8 | 2 | 2.19 | 2.48 | 0.29 | 2.54 | 0.35 | Indeterminate | Indeterminate |
9 | 12 | 1.58 | 3.01 | 1.43 | 2.32 | 0.74 | Indeterminate | Positive |
10 | 14 | 1.52 | 1.81 | 0.29 | 2.17 | 0.65 | Indeterminate | Indeterminate |
11 | 9 | 1.24 | 1.31 | 0.07 | 1.31 | 0.07 | Indeterminate | Indeterminate |
12 | 6 | 1.13 | 1.11 | −0.02 | 1.05 | −0.08 | Indeterminate | Indeterminate |